Literature DB >> 779447

Comparison of methods for differentiating among Serratia marcescens isolated from clinical specimens.

E Roemisch, F E Kocka.   

Abstract

Serotyping, biotyping and antibiotic resistance patterns were found to give consistent results for routine hospital surveillance of Serratia marcescens isolates. Bacteriocin typing showed variation between trials and was considered too variable and time-consuming for routine hospital surveillance.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 779447     DOI： 10.1093/ajcp/66.1.96

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN： 0002-9173            Impact factor:   2.493


  6 in total

1.  Relationship of K1 antigen to biotype in clinical isolates of Escherichia coli.

Authors:  R L Myerowitz; A C Albers; R B Yee; F Orskov
Journal:  J Clin Microbiol       Date:  1977-08       Impact factor: 5.948

2.  Biotyping of Serratia marcescens and its use in epidemiological studies.

Authors:  P A Grimont; F Grimont
Journal:  J Clin Microbiol       Date:  1978-07       Impact factor: 5.948

3.  In vitro activity of gentamicin, amikacin and netilmicin alone and in combination with carbenicillin against Serratia marcescens.

Authors:  S M Pogwizd; S A Lerner
Journal:  Antimicrob Agents Chemother       Date:  1976-12       Impact factor: 5.191

4.  Analysis of epidemiologic markers of nosocomial Serratia marcescens isolates with special reference to the Grimont biotyping system.

Authors:  J Sifuentes-Osornio; G M Ruiz-Palacios; D H Gröschel
Journal:  J Clin Microbiol       Date:  1986-02       Impact factor: 5.948

5.  Nosocomial multiply resistant Providencia stuartii: a long-term outbreak with multiple biotypes and serotypes at one hospital.

Authors:  F E Kocka; S Srinivasan; M Mowjood; H S Kantor
Journal:  J Clin Microbiol       Date:  1980-02       Impact factor: 5.948

6.  Effect of clavulanic acid on the in vitro synergism between carbenicillin and gentamicin against Serratia marcescens.

Authors:  T Sirisanthana; S A Lerner
Journal:  Antimicrob Agents Chemother       Date:  1979-04       Impact factor: 5.191
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.